Cancer Care Ontario | Cancer Care Ontario

Une mammographie est une radiographie du sein qui peut déceler des changements anormaux dans le sein, même lorsqu’ils peuvent être trop petits pour...

Guidelines and Advice

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update

Status: Current
ID: GL-1-A-2016-2

Oct 2017

Guidelines and Advice

Recommendations for the Treatment of Patients with Clinical Stage III Non-Small Cell Lung Cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance and the 2018 Society for Immunotherapy of Cancer Guidance

Status: In-Review
ID: GL END 7-3
Version: 4

Apr 2020

Ressources recommandées pour les patients et les familles

Cette page énumère les ressources sur le cancer pour soutenir les personnes atteintes du cancer, les membres de la famille et les soignants ou...

Mélanome

Drug

melphalan

Other Name(s): Alkeran®

Quick Link(s):

Drug Monograph, Patient Info Sheet

Jun 2019

Recommendations on screening for breast cancer in average-risk women aged 40–74 years

Mammographic Density and the Risk and Detection of Breast Cancer

Recommended Criteria of a Pre-printed Order (PPO): Oral Chemotherapy Take-home Prescriptions

Recommendations for the Safe Use and Handling of Oral Anti-Cancer Drugs (OACDs) in Community Pharmacy: A Pan-Canadian Consensus Guideline

Méthodologie

Managing System Pressures for Sarcoma Service Delivery in Ontario

Mammographie

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update

Recommendations for the Treatment of Patients with Clinical Stage III Non-Small Cell Lung Cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance and the 2018 Society for Immunotherapy of Cancer Guidance

Ressources recommandées pour les patients et les familles

Mélanome

melphalan

Pages